175 related articles for article (PubMed ID: 30698857)
1. Differential clinical impacts of tumour budding evaluated by the use of immunohistochemical and haematoxylin and eosin staining in stage II colorectal cancer.
Yamadera M; Shinto E; Kajiwara Y; Mochizuki S; Okamoto K; Shimazaki H; Hase K; Ueno H
Histopathology; 2019 Jun; 74(7):1005-1013. PubMed ID: 30698857
[TBL] [Abstract][Full Text] [Related]
2. Tumor Budding Detection by Immunohistochemical Staining is Not Superior to Hematoxylin and Eosin Staining for Predicting Lymph Node Metastasis in pT1 Colorectal Cancer.
Okamura T; Shimada Y; Nogami H; Kameyama H; Kobayashi T; Kosugi S; Wakai T; Ajioka Y
Dis Colon Rectum; 2016 May; 59(5):396-402. PubMed ID: 27050601
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma.
Ohtsuki K; Koyama F; Tamura T; Enomoto Y; Fujii H; Mukogawa T; Nakagawa T; Uchimoto K; Nakamura S; Nonomura A; Nakajima Y
Anticancer Res; 2008; 28(3B):1831-6. PubMed ID: 18630467
[TBL] [Abstract][Full Text] [Related]
4. Development of a semi-automated method for tumour budding assessment in colorectal cancer and comparison with manual methods.
Fisher NC; Loughrey MB; Coleman HG; Gelbard MD; Bankhead P; Dunne PD
Histopathology; 2022 Feb; 80(3):485-500. PubMed ID: 34580909
[TBL] [Abstract][Full Text] [Related]
5. Combined epithelial marker analysis of tumour budding in stage II colorectal cancer.
Slik K; Blom S; Turkki R; Välimäki K; Kurki S; Mustonen H; Haglund C; Carpén O; Kallioniemi O; Korkeila E; Sundström J; Pellinen T
J Pathol Clin Res; 2019 Jan; 5(1):63-78. PubMed ID: 30358171
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer.
Rieger G; Koelzer VH; Dawson HE; Berger MD; Hädrich M; Inderbitzin D; Lugli A; Zlobec I
Histopathology; 2017 Jun; 70(7):1044-1051. PubMed ID: 28061021
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of tumor budding as predictor of lymph node metastasis from superficial esophageal squamous cell carcinoma.
Fuchinoue K; Nemoto T; Shimada H; Tochigi N; Igarashi Y; Yajima S; Suzuki T; Oshima Y; Shibuya K
Esophagus; 2020 Apr; 17(2):168-174. PubMed ID: 31595396
[TBL] [Abstract][Full Text] [Related]
8. Tumour budding at invasive margins and outcome in colorectal cancer.
Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
[TBL] [Abstract][Full Text] [Related]
9. Digital image analysis of pan-cytokeratin stained tumor slides for evaluation of tumor budding in pT1/pT2 colorectal cancer: Results of a feasibility study.
Jepsen RK; Klarskov LL; Lippert MF; Novotny GW; Hansen TP; Christensen IJ; Høgdall E; Riis LB
Pathol Res Pract; 2018 Sep; 214(9):1273-1281. PubMed ID: 30017334
[TBL] [Abstract][Full Text] [Related]
10. Histopathological Significance and Prognostic Impact of Tumor Budding in Colorectal Cancer.
Mehta A; Goswami M; Sinha R; Dogra A
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2447-2453. PubMed ID: 30255698
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis between multilevel sectioning with conventional haematoxylin and eosin staining and immunohistochemistry for detecting nodal micrometastases with stage I and II colorectal cancers.
Wong YP; Shah SA; Shaari N; Mohamad Esa MS; Sagap I; Isa NM
Asian Pac J Cancer Prev; 2014; 15(4):1725-30. PubMed ID: 24641399
[TBL] [Abstract][Full Text] [Related]
12. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
[TBL] [Abstract][Full Text] [Related]
13. Tumor budding in colorectal carcinoma assessed by cytokeratin immunostaining and budding areas: possible involvement of c-Met.
Satoh K; Nimura S; Aoki M; Hamasaki M; Koga K; Iwasaki H; Yamashita Y; Kataoka H; Nabeshima K
Cancer Sci; 2014 Nov; 105(11):1487-95. PubMed ID: 25220207
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy.
Puppa G; Senore C; Sheahan K; Vieth M; Lugli A; Zlobec I; Pecori S; Wang LM; Langner C; Mitomi H; Nakamura T; Watanabe M; Ueno H; Chasle J; Conley SA; Herlin P; Lauwers GY; Risio M
Histopathology; 2012 Oct; 61(4):562-75. PubMed ID: 22765314
[TBL] [Abstract][Full Text] [Related]
15. Tumour budding as prognostic factor in stage I/II colorectal carcinoma.
Prall F; Nizze H; Barten M
Histopathology; 2005 Jul; 47(1):17-24. PubMed ID: 15982319
[TBL] [Abstract][Full Text] [Related]
16. High reproducibility is attainable in assessing histoprognostic parameters of pT1 colorectal cancer using routine histopathology slides and immunohistochemistry analyses.
Barel F; Auffret A; Cariou M; Kermarrec T; Samaison L; Bourhis A; Badic B; Jézéquel J; Cholet F; Bail JP; Marcorelles P; Nousbaum JB; Robaszkiewicz M; Doucet L; Uguen A
Pathology; 2019 Jan; 51(1):46-54. PubMed ID: 30477880
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer.
Alexander-Sefre F; Singh N; Ayhan A; Thomas JM; Jacobs IJ
Gynecol Oncol; 2004 Feb; 92(2):653-9. PubMed ID: 14766262
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratin-based assessment of tumour budding in colorectal cancer: analysis in stage II patients and prospective diagnostic experience.
Koelzer VH; Assarzadegan N; Dawson H; Mitrovic B; Grin A; Messenger DE; Kirsch R; Riddell RH; Lugli A; Zlobec I
J Pathol Clin Res; 2017 Jul; 3(3):171-178. PubMed ID: 28770101
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical evaluation of tumor budding for stratifying T1 colorectal cancer: optimal cut-off value and a novel computer-assisted semiautomatic method.
Takamatsu M; Kawachi H; Yamamoto N; Kobayashi M; Toyama Y; Maekawa T; Chino A; Saito S; Ueno M; Takazawa Y; Ishikawa Y
Mod Pathol; 2019 May; 32(5):675-683. PubMed ID: 30552417
[TBL] [Abstract][Full Text] [Related]
20. Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer.
Lai YH; Wu LC; Li PS; Wu WH; Yang SB; Xia P; He XX; Xiao LB
Colorectal Dis; 2014 Apr; 16(4):259-64. PubMed ID: 24118729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
